Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Crop Enhancement develop sustainable agrochemical formulations that employ environmentally friendly chemistry to improve crop yields.
IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.
Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.
Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients.
Mnemo Therapeutics specializes in biotechnology and life science.
Soteria is a biotechnology company that develops immunotherapies to treat cancer patients
SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies
Rheostat Therapeutics is a bio therapeutics company.
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
Genetron Health is a world-leading expert in precision medicine.
Verseau focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer.
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases.
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
MouSensor is an early-stage biotech company.
System1 Biosciences is a neurotherapeutics company.
Nohla Therapeutics is a biotechnology company that develops a shelf alternative to bone marrow transplants.
Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.
Alexandria Venture Investments has invested in 186 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Alexandria Venture Investments's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 17 different industry categories.
Among tracked funding rounds, Skyhawk Therapeutics received $133.0M in a Series Unknown round. Alexandria Venture Investments's total known invested capital is $7.4B.
Alexandria Venture Investments's average investment size is $50.9M across its portfolio of 186 companies.
Recent Alexandria Venture Investments portfolio additions include Crop Enhancement, IpiNovyx Bio, Skyhawk Therapeutics, Alphina Therapeutics, Mnemo Therapeutics. These companies were founded in 2020 or later.